Concepedia

Sandra Garcet

SG

Statistics

Publications

51

Citations

3.2K

H-Index

30

Active since

2015

Affiliations

Rockefeller University(Current)

Icahn School of Medicine at Mount Sinai

Cornell University

Tri-Institutional PhD Program in Chemical Biology

Innovaderm (Canada)

Sandra Garcet is an author at Rockefeller University specializing in dermatology, immunology, and inflammation.

ORCID

Publications per year

2015–2024

51

Publications

51

Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial

Emma Guttman‐Yassky, Patrick M. Brunner, Avidan U. Neumann et al. · Journal of the American Academy of Dermatology · 2018 · 338 citations · Full text

, , +14

Efficacy and safety of ustekinumab treatment in adults with moderate‐to‐severe atopic dermatitis

Saakshi Khattri, Patrick M. Brunner, Sandra Garcet et al. · Experimental Dermatology · 2016 · 216 citations · Full text

, , +15

An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease

Benjamin Ungar, Sandra Garcet, Juana Gonzalez et al. · Journal of Investigative Dermatology · 2016 · 210 citations

, , +16

Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab

Patrick M. Brunner, Ana B. Pavel, Saakshi Khattri et al. · Journal of Allergy and Clinical Immunology · 2018 · 197 citations · Full text

, , +14

Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients

Emma Guttman‐Yassky, Yael Renert‐Yuval, Jennifer Bares et al. · Allergy · 2021 · 142 citations · Full text

, , +17

1–5 of 51